Advanced Therapies: 'Artificial' vectors

Advanced Therapies: 'Artificial' vectors

Despite all the work done in gene therapy, the design of good vectors for delivery of therapeutic genes remains one of the field's key challenges. The key has been to use the chemically desirable elements of a virus without producing a toxic reaction in patients.

With a live viral vector, even after extensive processing and reduction, toxic elements often will persist along with the desirable parts derived from the organism.

Read the full 730 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers